Medicine Matters rheumatology

著者: Springer Healthcare
  • サマリー

  • Interviews with clinical experts, discussing key issues in rheumatology.
    Springer Healthcare, part of the Springer Nature group
    続きを読む 一部表示

あらすじ・解説

Interviews with clinical experts, discussing key issues in rheumatology.
Springer Healthcare, part of the Springer Nature group
エピソード
  • Repurposing rheumatology drugs for COVID-19: TNF inhibitors (with Philip Robinson)
    2021/03/09

    Philip Robinson discusses why TNF inhibitors may be a favorable treatment option for COVID-19 and outlines the trials that are currently underway.

    続きを読む 一部表示
    17 分
  • Repurposing rheumatology drugs for COVID-19: Interleukin inhibitors
    2021/02/11

    Cristina Mussini discusses the current data on interleukin inhibitors for the treatment of COVID-19 and explores why tocilizumab has been associated with beneficial outcomes in some studies but not others.

    続きを読む 一部表示
    19 分
  • Repurposing rheumatology drugs for COVID-19: JAK inhibitors
    2021/01/25

    Marwan Bukhari talks about the rationale behind investigating baricitinib and other JAK inhibitors for the treatment of COVID-19 and outlines the current efficacy data.

    続きを読む 一部表示
    11 分

Medicine Matters rheumatologyに寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。